Funds' Flonase Antitrust Suit Survives GSK Dismissal Bid

Law360, Los Angeles (September 26, 2011, 9:02 PM EDT) -- A Pennsylvania federal judge on Monday issued a split ruling on GlaxoSmithKline PLC’s bid for summary judgment in four health care funds' antitrust class action alleging it improperly delayed sales of a generic version of Flonase, striking some claims while keeping others alive.

In a 33-page decision that used charts to lay out a complex split ruling, U.S. District Judge Anita B. Brody analyzed whether each of the four health plans could show it had been injured by paying inflated drug prices for members in certain...
To view the full article, register now.